Avid Bioservices Inc (CDMO)

[EYEBUYSTOX]

It's your opinion, but you're wrong. The e-mail was drafted last month and the documents (bavi launch scenario #1 and #2) were given to opposing counsel in 2014, months after the Fast Track designation was granted. All the fast track does is take off 4 months of review time assuming a priority review is granted vs. a standard review. There would not be a year difference in "Fast Track" approval vs. standard approval. That's also a fact.

I'm hoping the increase in Avid is to support the other trials with a partner that should have been started by now (TNB and Liver...maybe melanoma?) so we don't just have one, giant shot on goal but several.